Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: The fushimi atrial fibrillation registry

Stroke

Volumn 46, Issue 12, 2015, Pages 3354-3361

  Takabayashi, Kensuke ^a   Hamatani, Yasuhiro ^a   Yamashita, Yugo ^a   Takagi, Daisuke ^a   Unoki, Takashi ^a   Ishii, Mitsuru ^a   Iguchi, Moritake ^a   Masunaga, Nobutoyo ^a   Ogawa, Hisashi ^a   Esato, Masahiro ^b   Chun, Yeong Hwa ^b   Tsuji, Hikari ^c   Wada, Hiromichi ^a   Hasegawa, Koji ^a   Abe, Mitsuru ^a   Lip, Gregory Y H ^d,e   Akao, Masaharu ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b Ijinkai Takeda General Hospital   (Japan)

^c Tsuji Clinic   (Japan)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e AALBORG UNIVERSITY   (Denmark)

Author keywords

atrial fibrillation; embolism; registries; risk factors; stroke

Indexed keywords

WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; ASIAN; BRAIN EMBOLISM; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAROXYSMAL ATRIAL FIBRILLATION; PERMANENT ATRIAL FIBRILLATION; PERSISTENT ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; STROKE PATIENT; ATRIAL FIBRILLATION; COMPARATIVE STUDY; EMBOLISM; INCIDENCE; JAPAN; MIDDLE AGED; MULTICENTER STUDY; REGISTER; RISK FACTOR; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COHORT STUDIES; EMBOLISM; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; STROKE;

EID: 84948085871     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.010947     Document Type: Article

References (24)

1. Kannel WB, Wolf PA, Benjamin EJ, Levy D., Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998 82 8A 2N 9N
2. Corbalán R, Arriagada D, Braun S, Tapia J, Huete I, Kramer A, Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation. Am Heart J 1992 124 149 153
3. Petersen P, Godtfredsen J., Embolic complications in paroxysmal atrial fibrillation. Stroke 1986 17 622 626
4. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, ACTIVE W Investigators Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol 2007 50 2156 2161. doi: 10.1016/j.jacc.2007.07.076.
5. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL., Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000 35 183 187
6. Friberg L, Hammar N, Rosenqvist M., Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2010 31 967 975. doi: 10.1093/eurheartj/ehn599.
7. Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. Int J Cardiol 2013 167 2682 2687. doi: 10.1016/j.ijcard.2012.06.118.
8. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, ESC Committee for Practice Guidelines-CPG; Document Reviewers 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 2012 14 1385 1413. doi: 10.1093/europace/eus305.
9. National Clinical Guideline Center (UK) Atrial Fibrillation: The Management of Atrial Fibrillation. National Institute for Health and Clinical Exellence: Guidance. 2014 London National Institute for Health and Care Excellence (UK). Jun. NICE Clinical Guidelines, No. 180
10. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014 64 e1 76. doi: 10.1016/j.jacc.2014.03.022.
11. Al-Khatib SM, Thomas L, Wallentin L, Lopes RD, Gersh B, Garcia D, Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur Heart J 2013 34 2464 2471. doi: 10.1093/eurheartj/eht135.
12. Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ, ROCKET-AF Steering Committee and Investigators Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J 2015 36 288 296. doi: 10.1093/eurheartj/ehu359.
13. Vanassche T, Lauw MN, Eikelboom JW, Healey JS, Hart RG, Alings M, Risk of ischaemic stroke according to pattern of atrial fiblillation: analysis of 6563 aspirin-Dreated patients in ACTIVE-A and AVERROES. Eur Heart J 2015 36 281 287
14. Nieuwlaat R, Dinh T, Olsson SB, Camm AJ, Capucci A, Tieleman RG, Euro Heart Survey Investigators Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 2008 29 915 922. doi: 10.1093/eurheartj/ehn101.
15. Inoue H, Atarashi H, Okumura K, Yamashita T, Kumagai N, Origasa H., Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation. Subanalysis of the J-RHYTHM Registry. Circ J 2014 78 2388 2393
16. JCS joint Working Group Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013). Circ J 2014 78 1997 2021
17. Akao M, Chun YH, Wada H, Esato M, Hashimoto T, Abe M, Fushimi AF Registry Investigators Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry. J Cardiol 2013 61 260 266. doi: 10.1016/j.jjcc.2012.12.002.
18. Akao M, Chun YH, Esato M, Abe M, Tsuji H, Wada H, Fushimi AF Registry Investigators Inappropriate use of oral anticoagulants for patients with atrial fibrillation. Circ J 2014 78 2166 2172
19. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ., Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001 285 2864 2870
20. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ., Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010 137 263 272. doi: 10.1378/chest.09-1584.
21. Hamatani Y, Ogawa H, Uozumi R, Iguchi M, Yamashita Y, Esato M, Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients-Insight From the Fushimi AF Registry. Circ J 2015 79 1009 1017. doi: 10.1253/circj.CJ-14-1245.
22. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, Italian AT500 Registry Investigators Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005 46 1913 1920. doi: 10.1016/j.jacc.2005.07.044.
23. Boriani G, Glotzer TV, Santini M, West TM, De Melis M, Sepsi M, Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J 2014 35 508 516. doi: 10.1093/eurheartj/eht491.
24. Boriani G, Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Italian AT-500 Registry Investigators Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke 2011 42 1768 1770. doi: 10.1161/STROKEAHA.110.609297.